Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215533 · ClinicalTrials.gov registry record · NA
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
A NA study of Metabolic Diseases and Time-restricted Eating, sponsored by Syracuse University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07215533: Recruiting NA study of Metabolic Diseases and Time-restricted Eating, sponsored by Syracuse University.
NCT07215533 is a NA study of Metabolic Diseases and Time-restricted Eating that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 40 participants, below the 195-participant average among 12 other Metabolic Diseases trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215533, a NA study of Metabolic Diseases and Time-restricted Eating, is actively recruiting participants, sponsored by Syracuse University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on cardiometabolic biomarkers in adolescents and young adults.
Primary Outcome
Weight is measured in kilograms (kg) using a calibrated digital scale.
Conditions Studied
Interventions
- BEHAVIORAL Time-restricted eating
- BEHAVIORAL High-intensity interval training
Study Locations (1)
New York
- Syracuse University - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT07215533 shows while recruiting
NCT07215533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 195-participant average among 12 other Metabolic Diseases trials with a reported enrollment target (79% lower).
The record links to 4 conditions, with Metabolic Diseases appearing as the primary indexed condition, and to 2 interventions - of which Time-restricted eating is the first listed.
NCT07215533 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07215533 about?
NCT07215533 is a clinical study titled "Effects of HIIT vs. TRE on Type 2 Diabetes Risk". The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on cardiometabolic biomarkers in adolescents and young adults.
What is the current status of trial NCT07215533?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-15. Estimated completion is 2025-12-30.
What conditions does trial NCT07215533 study?
This clinical trial studies the following conditions: Metabolic Diseases, Time-restricted Eating, Obesity and Type 2 Diabetes, High Intensity Interval Training.
What interventions are being tested in trial NCT07215533?
The interventions under investigation include: Time-restricted eating (BEHAVIORAL), High-intensity interval training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07215533?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215533 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07215533's enrollment target sits among peer trials
40 9th of 12 higher than 4 of 12 other Metabolic Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
The Effect of Processing on Food Reward
RECRUITING · NA
-
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
RECRUITING · NA
-
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
RECRUITING · Phase 4
-
Genetic and Metabolic Disease in Children
RECRUITING
-
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI